ARTIST MRI (AMPA [alpha-amino-3-hydroxy-5-methylisoxazole-4- propionic acid] Receptor Antagonist Treatment in Ischemic Stroke Trial-MRI [magnetic resonance imaging]) A randomized, double-blind, placebo-controlled study to evaluate effects of YM872 [zonampanel] on lesion volume as measured by diffusion, perfusion, and FLAIR [fast fluid-attenuated inversion-recovery] MRI In patients with acute ischemic stroke
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 15 May 2007
At a glance
- Drugs Zonampanel (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 15 May 2007 New trial record.